Literature DB >> 6408167

Human T lymphocyte proliferation induced by a pan-T monoclonal antibody (anti-Leu 4): heterogeneity of response is a function of monocytes.

H Kaneoka, G Perez-Rojas, T Sasasuki, C J Benike, E G Engleman.   

Abstract

Anti-Leu-4 is a murine monoclonal antibody that defines a molecule of 20,000 to 25,000 daltons present on all mature T lymphocytes in man. When cultured in the presence of 10 to 1000 ng/ml anti-Leu-4, the T cells of most individuals proliferate with peak responses on the third day of culture. T cells of both helper and suppressor lineages proliferate, but only in the presence of monocytes. Approximately 40% of individuals tested responded weakly or not at all to anti-Leu-4, despite normal responses to other stimuli. The variation in responsiveness between individuals could not be explained by differences in Leu-4 antigen density on the surface of T cells, differences in the rate of Leu-4 antigen modulation, or structural differences in the Leu-4 molecule as defined by the method of two-dimensional polyacrylamide gel electrophoresis. In the presence of monocytes from high responders, the T cells from low responders proliferated vigorously to anti-Leu-4, whereas monocytes from low responders failed to support proliferation by high responder T cells. On the other hand, low responder monocytes did not prevent T cells from proliferating in the presence of high responder monocytes. These results suggest that the failure of some individuals to respond to anti-Leu-4 is due to the absence or dysfunction of an essential monocyte population.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6408167

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  Proliferation of highly purified T cells in response to signaling via surface receptors requires cell-cell contact.

Authors:  D Schwartz; R C Wong; T Chatila; A Arnaout; R Miller; R Geha
Journal:  J Clin Immunol       Date:  1989-03       Impact factor: 8.317

2.  Stimulation of T cells through the CD3/T-cell receptor complex: role of cytoplasmic calcium, protein kinase C translocation, and phosphorylation of pp60c-src in the activation pathway.

Authors:  J A Ledbetter; L E Gentry; C H June; P S Rabinovitch; A F Purchio
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

3.  Role of monocytes in anti-CD3-induced T-cell DNA synthesis: effect of chloroquine and monensin on anti-CD3-induced human T-cell activation.

Authors:  B Vayuvegula; K Ohira; S Gollapudi; S Gupta
Journal:  J Clin Immunol       Date:  1990-09       Impact factor: 8.317

4.  Synthesis of anti-acetylcholine receptor antibodies by CD5- B cells from peripheral blood of myasthenia gravis patients.

Authors:  F Heidenreich; T Jovin
Journal:  J Neurol       Date:  1996-01       Impact factor: 4.849

5.  Synthetic macrophages: antigen presentation by liposomes bearing class II major histocompatibility complex (MHC) and membrane interleukin-1 (IL-1).

Authors:  O Bakouche; L B Lachman
Journal:  J Clin Immunol       Date:  1989-09       Impact factor: 8.317

6.  Polymorphism for RhT3, a CD3-like cell surface antigen, expressed on rhesus monkey T lymphocytes.

Authors:  F J Nooij; W van Vreeswijk; J Coolen
Journal:  Immunology       Date:  1986-12       Impact factor: 7.397

7.  A whole-blood assay for qualitative and semiquantitative measurements of CD69 surface expression on CD4 and CD8 T lymphocytes using flow cytometry.

Authors:  L C Lim; M N Fiordalisi; J L Mantell; J L Schmitz; J D Folds
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

8.  T cell blast stimulation of MLR: role of interleukin 1 and interleukin 2.

Authors:  S Aaron
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

9.  Isotype-specific cross-linking of select human Fc gamma R isoforms triggers release of IL-6.

Authors:  A J Duits; L A Aarden; L K Ernst; P J Capel; J G van de Winkel
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

10.  Increased proportion of responders to a murine anti-CD3 monoclonal antibody of the IgG1 class in patients with systemic lupus erythematosus (SLE).

Authors:  A M Blasini; I L Stekman; M Leon-Ponte; D Caldera; M A Rodriguez
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.